Sean Laaman
Stock Analyst at Morgan Stanley
(4.64)
# 874
Out of 5,055 analysts
600
Total ratings
58.4%
Success rate
11.6%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALEC Alector | Maintained: Sell | $3 | $1.87 | +60.43% | 8 | Oct 14, 2026 | |
| ASND Ascendis Pharma | Rated: Buy | $273 | $223.21 | +22.31% | 1 | Oct 12, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Hold | $17 | $8.42 | +101.90% | 11 | Oct 12, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,250 → $1,140 | $802.64 | +42.03% | 14 | Oct 9, 2026 | |
| ELVN Enliven Therapeutics | Initiated Coverage: Buy | $70 | $39.49 | +77.26% | 1 | Oct 5, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Hold | $251 → $247 | $156.32 | +58.01% | 11 | Sep 25, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $124 | $54.38 | +128.03% | 11 | Sep 16, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $30 | $14.10 | +112.77% | 11 | Sep 15, 2026 | |
| NBIX Neurocrine Biosciences | Rated: Hold | $182 → $183 | $135.13 | +35.43% | 22 | Sep 11, 2026 | |
| RVMD Revolution Medicines | Initiated Coverage: Buy | $255 | $188.44 | +35.32% | 1 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $283 → $322 | $210.39 | +53.05% | 18 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 → $28 | $18.62 | +50.38% | 14 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $10 | $9.10 | +9.89% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 | $2.95 | +510.17% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 | $62.40 | +49.04% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $6.72 | +376.19% | 2 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $14.78 | +42.08% | 8 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 | $12.26 | +79.52% | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $85 → $90 | $56.60 | +59.01% | 13 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $7.88 | +166.67% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5.5 → $5.3 | $3.84 | +38.20% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $97 | $63.30 | +53.24% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $40 | $18.40 | +117.39% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 → $105 | $109.62 | -4.21% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $43 | $27.82 | +54.57% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 | $59.51 | -10.94% | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $395 → $405 | $349.08 | +16.02% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $17 | $25.89 | -34.34% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.30 | $2.81 | n/a | 19 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $9.60 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.80 → $3.95 | $4.66 | n/a | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $235.04 | n/a | 13 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.70 | $33.58 | n/a | 16 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $310.00 | $184.59 | n/a | 68 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.60 → $31.65 | $18.37 | n/a | 34 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25.38 → $24.14 | $45.56 | n/a | 18 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26.75 → $28.76 | $48.70 | n/a | 5 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $276.00 → $256.00 | $129.28 | n/a | 21 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.30 | $0.38 | n/a | 29 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.15 → $7.35 | $6.48 | n/a | 21 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.45 → $1.65 | $0.76 | n/a | 15 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48.53 → $47.28 | $19.78 | n/a | 10 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53.60 → $51.60 | $54.65 | n/a | 27 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.70 → $2.75 | $2.10 | n/a | 13 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.75 | n/a | 2 | Aug 24, 2021 |
Alector
Oct 14, 2026
Maintained: Sell
Price Target: $3
Current: $1.87
Upside: +60.43%
Ascendis Pharma
Oct 12, 2026
Rated: Buy
Price Target: $273
Current: $223.21
Upside: +22.31%
Contineum Therapeutics
Oct 12, 2026
Reiterated: Hold
Price Target: $17
Current: $8.42
Upside: +101.90%
argenx SE
Oct 9, 2026
Reiterated: Buy
Price Target: $1,250 → $1,140
Current: $802.64
Upside: +42.03%
Enliven Therapeutics
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $39.49
Upside: +77.26%
Axsome Therapeutics
Sep 25, 2026
Reiterated: Hold
Price Target: $251 → $247
Current: $156.32
Upside: +58.01%
BioMarin Pharmaceutical
Sep 16, 2026
Rated: Buy
Price Target: $124
Current: $54.38
Upside: +128.03%
Cullinan Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $30
Current: $14.10
Upside: +112.77%
Neurocrine Biosciences
Sep 11, 2026
Rated: Hold
Price Target: $182 → $183
Current: $135.13
Upside: +35.43%
Revolution Medicines
Sep 10, 2026
Initiated Coverage: Buy
Price Target: $255
Current: $188.44
Upside: +35.32%
Aug 26, 2026
Rated: Buy
Price Target: $283 → $322
Current: $210.39
Upside: +53.05%
Aug 25, 2026
Rated: Hold
Price Target: $27 → $28
Current: $18.62
Upside: +50.38%
Aug 17, 2026
Rated: Hold
Price Target: $10
Current: $9.10
Upside: +9.89%
Aug 17, 2026
Rated: Buy
Price Target: $18
Current: $2.95
Upside: +510.17%
Aug 17, 2026
Rated: Buy
Price Target: $93
Current: $62.40
Upside: +49.04%
Aug 17, 2026
Rated: Buy
Price Target: $32
Current: $6.72
Upside: +376.19%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $14.78
Upside: +42.08%
Aug 17, 2026
Rated: Buy
Price Target: $22
Current: $12.26
Upside: +79.52%
Aug 17, 2026
Rated: Buy
Price Target: $85 → $90
Current: $56.60
Upside: +59.01%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $7.88
Upside: +166.67%
Aug 17, 2026
Rated: Hold
Price Target: $5.5 → $5.3
Current: $3.84
Upside: +38.20%
Aug 11, 2026
Reiterated: Buy
Price Target: $98 → $97
Current: $63.30
Upside: +53.24%
Aug 7, 2026
Rated: Buy
Price Target: $36 → $40
Current: $18.40
Upside: +117.39%
Aug 7, 2026
Rated: Buy
Price Target: $93 → $105
Current: $109.62
Upside: -4.21%
Aug 7, 2026
Reiterated: Hold
Price Target: $40 → $43
Current: $27.82
Upside: +54.57%
Aug 6, 2026
Reiterated: Hold
Price Target: $53
Current: $59.51
Upside: -10.94%
Aug 6, 2026
Reiterated: Buy
Price Target: $395 → $405
Current: $349.08
Upside: +16.02%
May 14, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $25.89
Upside: -34.34%
Aug 28, 2025
Reiterated: Buy
Price Target: $3.30
Current: $2.81
Upside: n/a
Jul 2, 2025
Initiated Coverage: Hold
Price Target: $16
Current: $9.60
Upside: n/a
Feb 12, 2025
Reiterated: Hold
Price Target: $3.80 → $3.95
Current: $4.66
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $235.04
Upside: n/a
Jun 24, 2024
Reiterated: Buy
Price Target: $33.70
Current: $33.58
Upside: n/a
Jun 12, 2024
Reiterated: Buy
Price Target: $310.00
Current: $184.59
Upside: n/a
May 22, 2024
Reiterated: Buy
Price Target: $33.60 → $31.65
Current: $18.37
Upside: n/a
Apr 9, 2024
Reiterated: Hold
Price Target: $25.38 → $24.14
Current: $45.56
Upside: n/a
Mar 22, 2024
Reiterated: Hold
Price Target: $26.75 → $28.76
Current: $48.70
Upside: n/a
Mar 21, 2024
Reiterated: Sell
Price Target: $276.00 → $256.00
Current: $129.28
Upside: n/a
Feb 28, 2024
Reiterated: Sell
Price Target: $1.30
Current: $0.38
Upside: n/a
Feb 27, 2024
Reiterated: Hold
Price Target: $8.15 → $7.35
Current: $6.48
Upside: n/a
Feb 26, 2024
Reiterated: Buy
Price Target: $1.45 → $1.65
Current: $0.76
Upside: n/a
Jan 12, 2024
Reiterated: Buy
Price Target: $48.53 → $47.28
Current: $19.78
Upside: n/a
Nov 28, 2023
Reiterated: Hold
Price Target: $53.60 → $51.60
Current: $54.65
Upside: n/a
Aug 28, 2023
Reiterated: Sell
Price Target: $2.70 → $2.75
Current: $2.10
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: n/a
Current: $12.75
Upside: n/a